Wikidata

(Q45746238)

English

2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA).

scientific article published on 15 September 2008

In more languages

Statements

title
2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA) (English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
3334176
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC3334176&resulttype=core&format=json
retrieved
8 May 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45746238&oldid=1867744939"